Detalhe da pesquisa
1.
SGN-CD228A Is an Investigational CD228-Directed Antibody-Drug Conjugate with Potent Antitumor Activity across a Wide Spectrum of Preclinical Solid Tumor Models.
Mol Cancer Ther
; 22(4): 421-434, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36800443
2.
Improving Antibody-Tubulysin Conjugates through Linker Chemistry and Site-Specific Conjugation.
ChemMedChem
; 16(7): 1077-1081, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33369163
3.
Characteristics and risk factors for poor outcome in patients with systemic vasculitis involving the gastrointestinal tract.
Semin Arthritis Rheum
; 51(2): 436-441, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33711774
4.
Glucuronide-Linked Antibody-Tubulysin Conjugates Display Activity in MDR+ and Heterogeneous Tumor Models.
Mol Cancer Ther
; 17(8): 1752-1760, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29866744
5.
Effects of Cationic Proteins on Gold Nanoparticle/Aptamer Assays.
ACS Omega
; 2(11): 8222-8226, 2017 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29214237
6.
Development of Novel Quaternary Ammonium Linkers for Antibody-Drug Conjugates.
Mol Cancer Ther
; 15(5): 938-45, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26944920